Kamlesh K. Yadav, Ph.D.
Affiliations: | 2011 | Basic Medical Science | New York University, New York, NY, United States |
Area:
Biochemistry, Molecular Biology, Cell BiologyGoogle:
"Kamlesh Yadav"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Dafna Bar-Sagi | grad student | 2011 | NYU | |
| (Regulation of the Ras-MAPK pathway by the guanine-nucleotide exchange factor Son of Sevenless.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Woo J, Santasusagna S, Banks J, et al. (2020) Urine Extracellular Vesicle GATA2 mRNA Discriminates Biopsy Result in Men with Suspicion of Prostate Cancer. The Journal of Urology. 101097JU000000000000 |
| Mohamed NE, Tewari AK, Yadav KK. (2019) Development and validation of a polygenic hazard score for aggressive prostate cancer identification Translational Cancer Research. 8 |
| Woo J, Santasusagna S, Leiby B, et al. (2019) GATA2 exosomal mRNA: A novel urine biomarker for the diagnosis of clinically significant prostate cancer. Journal of Clinical Oncology. 37: 18-18 |
| Woo J, Santasusagna S, Banks J, et al. (2019) Urine extracellular vesicle GATA2 mRNA alone and in a multigene test predicts initial prostate biopsy result Annals of Oncology. 30: v349 |
| Beksac AT, Cumarasamy S, Falagario U, et al. (2018) Multiparametric Magnetic Resonance Imaging Features Identify Aggressive Prostate Cancer at the Phenotypic and Transcriptomic Level. The Journal of Urology. 200: 1241-1249 |
| Olsson CA, Lavery HJ, Yadav KK, et al. (2018) Histologic Changes in Prostate Cancer Detected Subsequent to the 2012 United States Preventive Services Task Force (USPSTF) Prostate Cancer Screening Recommendation. Reviews in Urology. 20: 125-130 |
| Yadav KK. (2018) How AI Is Optimizing the Detection and Management of Prostate Cancer. Ieee Pulse. 9: 19 |
| Tewari AK, Stockert JA, Yadav SS, et al. (2018) Inflammation and Prostate Cancer. Advances in Experimental Medicine and Biology. 1095: 41-65 |
| Hieronymus H, Murali R, Tin A, et al. (2018) Tumor copy number alteration burden is a pan-cancer prognostic factor associated with recurrence and death. Elife. 7 |
| Yadav SS, Stockert JA, Hackert V, et al. (2018) Intratumor heterogeneity in prostate cancer. Urologic Oncology |